- Home
- MNOV vs MGRM Comparison
MNOV vs MGRM Comparison
Compare MNOV & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- MGRM
- Stock Information
- Founded
- MNOV 2000
- MGRM 2016
- Country
- MNOV United States
- MGRM United States
- Employees
- MNOV N/A
- MGRM N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- MGRM Medical/Dental Instruments
- Sector
- MNOV Health Care
- MGRM Health Care
- Exchange
- MNOV Nasdaq
- MGRM Nasdaq
- Market Cap
- MNOV 87.3M
- MGRM 89.6M
- IPO Year
- MNOV 2005
- MGRM N/A
- Fundamental
- Price
- MNOV $1.83
- MGRM $2.57
- Analyst Decision
- MNOV Strong Buy
- MGRM Strong Buy
- Analyst Count
- MNOV 1
- MGRM 1
- Target Price
- MNOV $9.00
- MGRM $4.00
- AVG Volume (30 Days)
- MNOV 37.0K
- MGRM 63.8K
- Earning Date
- MNOV 02-13-2025
- MGRM 03-14-2025
- Dividend Yield
- MNOV N/A
- MGRM N/A
- EPS Growth
- MNOV N/A
- MGRM N/A
- EPS
- MNOV N/A
- MGRM N/A
- Revenue
- MNOV N/A
- MGRM $364,999.00
- Revenue This Year
- MNOV N/A
- MGRM N/A
- Revenue Next Year
- MNOV N/A
- MGRM N/A
- P/E Ratio
- MNOV N/A
- MGRM N/A
- Revenue Growth
- MNOV N/A
- MGRM N/A
- 52 Week Low
- MNOV $1.12
- MGRM $1.53
- 52 Week High
- MNOV $2.55
- MGRM $4.90
- Technical
- Relative Strength Index (RSI)
- MNOV 35.00
- MGRM 54.65
- Support Level
- MNOV $1.90
- MGRM $2.35
- Resistance Level
- MNOV $2.20
- MGRM $2.80
- Average True Range (ATR)
- MNOV 0.08
- MGRM 0.20
- MACD
- MNOV -0.03
- MGRM -0.01
- Stochastic Oscillator
- MNOV 0.00
- MGRM 54.00
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.